loading
Protara Therapeutics Inc stock is traded at $3.30, with a volume of 412.86K. It is up +8.55% in the last 24 hours and down -7.82% over the past month. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
See More
Previous Close:
$3.04
Open:
$3.08
24h Volume:
412.86K
Relative Volume:
1.19
Market Cap:
$127.31M
Revenue:
-
Net Income/Loss:
$-42.05M
P/E Ratio:
-1.1702
EPS:
-2.82
Net Cash Flow:
$-35.26M
1W Performance:
+5.43%
1M Performance:
-7.82%
6M Performance:
+30.43%
1Y Performance:
+17.44%
1-Day Range:
Value
$3.08
$3.36
1-Week Range:
Value
$3.02
$3.36
52-Week Range:
Value
$1.595
$10.48

Protara Therapeutics Inc Stock (TARA) Company Profile

Name
Name
Protara Therapeutics Inc
Name
Phone
646-844-0337
Name
Address
345 PARK AVENUE SOUTH, NEW YORK, NY
Name
Employee
33
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
TARA's Discussions on Twitter

Compare TARA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TARA
Protara Therapeutics Inc
3.30 121.92M 0 -42.05M -35.26M -2.82
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-16-25 Initiated Scotiabank Sector Outperform
Mar-14-25 Initiated Cantor Fitzgerald Overweight
Jul-10-23 Resumed Guggenheim Buy
Jun-04-21 Initiated H.C. Wainwright Buy
Feb-17-21 Initiated Oppenheimer Outperform
Oct-19-20 Initiated Cowen Outperform
Jul-29-20 Initiated Guggenheim Buy
View All

Protara Therapeutics Inc Stock (TARA) Latest News

pulisher
04:00 AM

Millennium Management LLC Purchases 357,051 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

04:00 AM
pulisher
Jun 02, 2025

Protara Therapeutics names new Chief Commercial Officer - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics (TARA) Appoints New Chief Commercial Officer | TARA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Names William Conkling as Chief Commercial Officer - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment Of William Conkling As Chief Commercial Officer - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer | TARA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan

Jun 02, 2025
pulisher
May 29, 2025

Transcript : Protara Therapeutics, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 01 - marketscreener.com

May 29, 2025
pulisher
May 22, 2025

Jones Trading Initiates Coverage of Protara Therapeutics (TARA) with Buy Recommendation - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating | TARA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Receives Buy Rating with $21 Price T - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Jones Initiates Protara Therapeutics at Buy With $21 Price Target - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Richard Levy Spends US$64k On Protara Therapeutics Stock - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

BNP Paribas Financial Markets Purchases Shares of 151,906 Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 22, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Makes New $111,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 18, 2025
pulisher
May 17, 2025

Richard Levy Bought 65% More Shares In Protara Therapeutics - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Insider Buying: Richard Levy Acquires 20,000 Shares of Protara T - GuruFocus

May 17, 2025
pulisher
May 16, 2025

With 73% ownership, Protara Therapeutics, Inc. (NASDAQ:TARA) boasts of strong institutional backing - Yahoo Finance

May 16, 2025
pulisher
May 13, 2025

Protara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 13, 2025
pulisher
May 11, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of “Buy” from Brokerages - Defense World

May 11, 2025
pulisher
May 10, 2025

Protara Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 10, 2025
pulisher
May 09, 2025

Protara Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Takes $492,000 Position in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 09, 2025
pulisher
May 08, 2025

Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC with Strong Efficacy and Safety Profile - TipRanks

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TA - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics (TARA) Sees Positive Results in TARA-002 Trial | TARA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TARA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics Q1 2025 Financial Results and Business Update - TradingView

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Buys 9,553 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 02, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Sells 194,440 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 02, 2025
pulisher
May 01, 2025

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Protara Therapeutics Expands Leadership Team: New CPO Receives 61,500 Equity Awards Amid Growth Push - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Stocks of Protara Therapeutics Inc (TARA) are poised to climb above their peers - Sete News

May 01, 2025
pulisher
Apr 30, 2025

It would be worthwhile to take a closer look at Protara Therapeutics Inc (TARA) - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Protara Therapeutics, Inc.'s (NASDAQ:TARA) institutional investors lost 14% last week but have benefitted from longer-term gains - simplywall.st

Apr 30, 2025
pulisher
Apr 30, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Shares Sold by LPL Financial LLC - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

The Potential Rise in the Price of Protara Therapeutics Inc (TARA) following insiders activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Biotech Co. Achieves Remarkable Cancer Treatment Results in Trial - streetwisereports.com

Apr 29, 2025
pulisher
Apr 29, 2025

Protara Therapeutics Inc Inc. (TARA) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Balance Sheet Breakdown: Protara Therapeutics Inc (TARA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Protara Therapeutics (NASDAQ:TARA) Given “Buy” Rating at HC Wainwright - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Protara Therapeutics stock drops following interim trial results By Investing.com - Investing.com Nigeria

Apr 28, 2025
pulisher
Apr 28, 2025

Protara Therapeutics stock drops following interim trial results - Investing.com Australia

Apr 28, 2025

Protara Therapeutics Inc Stock (TARA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Cap:     |  Volume (24h):